Go Pro

Northwest Biotherapeutics (NWBO) Institutional Ownership

Northwest Biotherapeutics logo
$0.17 0.00 (-1.29%)
As of 03:59 PM Eastern

Institutional Ownership Changes (13F Filings) for Northwest Biotherapeutics (OTCMKTS:NWBO)

Current
Institutional Ownership
Percentage
0.04%
Number of
Institutional Buyers
(last 12 months)
1
Total
Institutional Inflows
(last 12 months)
$449.98K
Number of
Institutional Sellers
(last 12 months)
0
Get NWBO Insider Trade Alerts

Want to know when executives and insiders are buying or selling Northwest Biotherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Northwest Biotherapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/22/2026 Compass Financial Management LLC1,215,500$227K0.0%N/A0.072%
8/12/2026 Compass Financial Management LLC1,215,500$227K0.0%N/A0.072%


NWBO Institutional Ownership - Frequently Asked Questions

During the previous two years, the following institutional investors and hedge funds held shares of Northwest Biotherapeutics shares: Compass Financial Management LLC ($227K).Learn more on Northwest Biotherapeutics' institutional investors.

0.04% of Northwest Biotherapeutics' stock is owned by institutional investors. Learn more on NWBO's institutional investor holdings.

The following institutional investors have purchased Northwest Biotherapeutics' stock in the last 24 months: Compass Financial Management LLC ($2.43M).

Institutional investors have bought a total of 2,431,000 shares in the last 24 months. This purchase volume represents approximately $449.98K in transactions.



Institutional ownership data for OTCMKTS:NWBO is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 8/22/2026. New 13F filings are added each quarter as they're published.
From Our Partners